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Toll-like receptors (TLRs) are germline-encoded pattern recognition receptors (PRRs) that play a central role
in host cell recognition and responses to microbial pathogens. TLR-mediated recognition of components
derived from a wide range of pathogens and their role in the subsequent initiation of innate immune
responses is widely accepted; however, the recent discovery of non-TLR PRRs, such as C-type lectin recep-
tors, NOD-like receptors, and RIG-I-like receptors, suggests that many aspects of innate immunity are more
sophisticated and complex. In this review, we will focus on the role played by TLRs in mounting pro-
tective immune responses against infection and their crosstalk with other PRRs with respect to pathogen
recognition.Introduction
Recognition of microbial pathogens is an essential element for
the initiation of innate immune responses such as inflammation
and is mediated by germline-encoded pattern-recognition
receptors (PRRs) that recognize molecular structures that are
broadly shared by pathogens, known as pathogen-associated
molecular patterns (PAMPs) (Janeway, 1989). Upon PAMP
recognition, PRRs initiate a serious of signaling programs that
execute the first line of host defensive responses necessary for
killing infectious microbes. In addition, PRR signaling simulta-
neously induces maturation of dendritic cells (DCs), which is
responsible for alerting induction of the second line of host
defense, so-called adaptive immunity.
Toll-like receptors (TLRs) were the first PRRs to be identified.
They are also the most well characterized and recognize a wide
range of PAMPs (Akira et al., 2006; Beutler, 2009; Hoffmann,
2003;Medzhitov, 2007). TLRs are type I transmembrane proteins
and comprise an ectodomain, which contains leucine-rich
repeats that mediate the recognition of PAMPs, a transmem-
brane region, and cytosolic Toll-IL-1 receptor (TIR) domains
that activate downstream signaling pathways. They are ex-
pressed either on the cell surface or associated with intracellular
vesicles. To date, 10 and 12 functional TLRs have been identified
in human and mouse, respectively. Each TLR detects distinct
PAMPs derived from viruses, bacteria, mycobacteria, fungi,
and parasites. These include lipoproteins (recognized by TLR1,
TLR2, and TLR6), double-stranded (ds) RNA (TLR3), lipopolysac-
charide (LPS) (TLR4), flagellin (TLR5), single-stranded (ss) RNA
(TLR7 and TLR8), and DNA (TLR9) (Table 1; Akira et al., 2006).
Upon recognition of respective PAMPs, TLRs recruit a specific
set of adaptor molecules that harbor TIR domain, such as
MyD88 and TRIF, and initiate downstream signaling events
that leads to the secretion of inflammatory cytokines, type I
IFN, chemokines, and antimicrobial peptides (Kawai and Akira,
2010). These responses cause recruitment of neutrophils, acti-
vation of macrophages, and induction of IFN-stimulated genes,
resulting in direct killing of the infected pathogens. Moreover,activation of TLR signaling leads to maturation of DCs, contrib-
uting to the induction of adaptive immunity.
Although TLRs play a central role in the initiation of immune
responses against a number of pathogens, it has become
apparent that PRRs other than TLRs are also involved in PAMP
recognition and the control of innate immunity (Table 1). These
include membrane-bound C-type lectin receptors (CLRs), cyto-
solic proteins such as NOD-like receptors (NLRs) and RIG-I-like
receptors (RLRs), and unidentified proteins that mediate sensing
of cytosolic DNA or retrovirus infection (see reviews in this issue
of Immunity by Osorio and Reis e Sousa, 2011; Loo and Gale,
2011; Elinav et al., 2011). CLRs are a large superfamily of
membrane proteins comprising one or more C-type lectin-like
domains, which largely elicit inflammatory responses by recog-
nizing fungal and bacterial PAMPs. RLRs, which include RIG-I,
MDA5, and LGP2, are RNA helicases that recognize RNA
species released into the cytoplasm in a variety of cell types
and coordinate antiviral programs via type I IFN induction. The
NLR family comprises more than 20 members. NLRs are ex-
pressed intracellularly and respond to various PAMPs to trigger
inflammatory responses. Several NLRs such as NALP1 (NLRP1)
and NALP3 (NLRP3) form the inflammasomes along with ASC
and Caspase-1 and mediate processing of pro-IL-1b to mature
IL-1b for releases. DAI and IFI16 are candidate cytosolic dsDNA
sensors and induce type I IFN production whereas AIM2 recog-
nizes dsDNA and induces the secretion of IL-1b (Barbalat et al.,
2011; Barber, 2011).
Intact microbial pathogens are usually composed of a number
of PAMPs, which activate multiple PRRs. Moreover, different
PRRs may recognize the same PAMP (Table 1). Hence, TLRs,
in concert with other PRRs, orchestrate both pathogen-specific
and cell type-specific host immune responses to fight infections.
Here, we describe the role of TLRs in inducing innate immune
responses and in shaping the adaptive immune responses to
various pathogens, including bacteria, viruses, fungi, and proto-
zoan parasites. The crosstalk between TLRs and other PRRs in
mounting effective immune responses is also discussed.Immunity 34, May 27, 2011 ª2011 Elsevier Inc. 637
Table 1. PAMP Detection by TLRs and Other PRRs
Species PAMPs TLR Usage PRRs Involved in Recognition
Bacteria, mycobacteria LPS TLR4
lipoproteins, LTA, PGN, lipoarabinomannan TLR2/1, TLR2/6 NOD1, NOD2, NALP3, NALP1
flagellin TLR5 IPAF, NAIP5
DNA TLR9 AIM2
RNA TLR7 NALP3
Viruses DNA TLR9 AIM2, DAI, IFI16
RNA TLR3, TLR7, TLR8 RIG-I, MDA5, NALP3
structural protein TLR2, TLR4




Parasites tGPI-mutin (Trypanosoma) TLR2
glycoinositolphospholipids (Trypanosoma) TLR4
DNA TLR9
hemozoin (Plasmodium) TLR9 NALP3
profilin-like molecule (Toxoplasma gondii) TLR11
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TLR1, TLR2, TLR4, TLR5, and TLR6 are localized on the cell
surface and largely recognize microbial membrane components
whereas TLR3, TLR7, TLR8, and TLR9 are expressed within
intracellular vesicles and recognize nucleic acids (Blasius and
Beutler, 2010). Recently, it was shown that TLR11, a relative of
TLR5 expressed on the cell surface, is also expressed in intracel-
lular compartments (Pifer et al., 2011). TLR13 is also expressed
in intracellular vesicles although its cognate PAMP has not yet
been identified (Blasius and Beutler, 2010).
Intracellular vesicles within DCs and other innate immune
cells, in which TLR3, TLR7, TLR8, and TLR9 are localized,
include the endoplasmic reticulum (ER), endosomes, lysosomes,
and endolysosomes (Blasius and Beutler, 2010). The intracellular
localization enables TLRs to recognize nucleic acids delivered to
the intracellular compartments after the uptake of viruses and
other pathogens or infected cells. By contrast, cellular nucleic
acids present in the extracellular environment are rapidly
degraded by nucleases and do not access these intracellular
vesicles. Therefore, intracellular localization is important for
avoiding contact with ‘‘self’’ nucleic acids, a process that would
otherwise risk the initiation of autoimmune diseases. TLR3,
TLR7, TLR8, and TLR9 are sequestered in the ER and are deliv-
ered to the endosomes (where they encounter and respond to
their cognate PAMPs) via Golgi apparatus. Once inside the en-
dosomes, the N-terminal region of the TLRs is processed by
multiple lysosomal proteases, including cathepsins and aspara-
gine endopeptidase, to generate functional receptors that elicit
signaling (Blasius and Beutler, 2010; Ewald et al., 2011).
UNC93B1 is a 12 membrane-spanning protein present in the
ER and its mutation abrogates cytokine production and the up-
regulation of costimulatory molecules in response to TLR3,
TLR7, and TLR9 ligands (Tabeta et al., 2006). UNC93B1 interacts
with these TLRs and regulates their trafficking from the ER to the
endosomal compartments (Figure 1; Brinkmann et al., 2007; Kim638 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.et al., 2008). UNC93B1 interacts more strongly with TLR9 than
TLR7, resulting in a bias toward TLR9 sensing (Fukui et al.,
2009). Although it is thought that TLR11 is expressed on the
cell surface, it also interacts with UNC93B1 within the intracel-
lular vesicles (Pifer et al., 2011). Thus, it is possible that
UNC93B1 controls the mobilization of not only nucleic acid-
sensing TLRs but also at least one protein-sensing TLR.
TLR mobilization is also controlled by other proteins within the
ER, including PRAT4A and gp96. PRAT4A regulates the exit of
TLR1, TLR2, TLR4, TLR7, and TLR9 from the ER and their
respective trafficking to the plasmamembrane and endososmes
(Figure 1; Saitoh and Miyake, 2009). However, it does not influ-
ence TLR3 trafficking, which suggests that trafficking of TLR3
is differentially regulated from that of TLR7 and TLR9. gp96,
amember of ER-resident heat-shock protein 90 family, functions
as a general chaperone for most TLRs, including cell surface
TLR1, TLR2, TLR4, and TLR5 and intracellular TLR7 and TLR9
(Saitoh and Miyake, 2009).
TLR Signaling Pathways
After recognizing their respective PAMPs, TLRs activate
signaling pathways that provide specific immunological re-
sponses tailored to the microbes expressing that PAMP. The
specific response initiated by individual TLRs depends on the
recruitment of a single, or a specific combination of, TIR-
domain-containing adaptor protein (e.g., MyD88, TIRAP, TRIF,
or TRAM) (Figure 1; Kawai and Akira, 2010). MyD88 is utilized
by all TLRs (with the exception of TLR3) and members of IL-1
receptor family and transmits signals culminating in NF-kB and
MAP kinase activation and the induction of inflammatory cyto-
kines. TLR3 and TLR4 use TRIF to activate an alternative
pathway leading to the activation of NF-kB and IRF3 and the
induction of type I IFN and inflammatory cytokine productions.
TLR2 and TLR4 use TIRAP as an additional adaptor to recruit
MyD88. TRAM acts as a bridge between TLR4 and TRIF.
Figure 1. TLR Trafficking and Signaling
Individual TLRs initiate overlapping and distinct signaling pathways in various cell types such as macrophages (MP), conventinal DC (cDC), plasmacytoid DC
(pDC), lamina propria DC (LPDC), and inflammatory monocytes (iMO). PAMP engagement induces conformational changes of TLRs that allow homo- or het-
erophilic interactions of TLRs and recruitment of adaptor proteins such asMyD88, TIRAP, TRIF, and TRAM. TLR5, which is highly expressed on the cell surface of
LPDC, usesMyD88 and activates NF-kB through IRAKs, TRAF6, TAK1, and IKK complex, resulting in induction of inflammatory cytokines. Heterodimers of TLR1-
TLR2 and TLR2-TLR6 are also expressed on the cell surface and induce NF-kB activation through recruitment of TIRAP andMyD88 inmacrophages and cDCs. In
iMO, TLR2 is found to be expressed within the endosome and induce type I IFN via IRF3 and IRF7 in response to viruses. TLR4, which is expressed on the cell
surface, initially transmits signals for the early-phase activation of NF-kB by recruiting TIRAP and MyD88. TLR4 is then transported into Rab11a-positive
phagosomes that contain bacteria, where it recruits TRAMand TRIF and activates TRAF3-TBK1-IRF3 axis aswell as late-phaseNF-kBactivation for the induction
of type I IFN. Both early- and late-phase activation of NF-kB is required for the induction of inflammatory cytokines. TLR3, TLR7, and TLR9 are localized mainly to
the ER in the steady state and traffic to the endosomal compartment, where they engage with their ligands. UNC93B1, which interacts with these TLRs in the ER,
mediates this trafficking. The translocation of TLR7 and TLR9 from the ER to the endosome is also regulated by PRAT4A, which also supports the translocation of
TLR4 and TLR1 to the cell surface. Amember of ER-resident gp96 functions as a general chaperone for most TLRs including TLR1, TLR2, TLR4, TLR5, TLR7, and
TLR9 (not shown here). TLR3 activates the TRIF-dependent pathway to induce type I IFN and inflammatory cytokines in macrophages and cDCs. In pDCs, TLR7
and TLR9 activate NF-kB and IRF7 viaMyD88 to induce inflammatory cytokines and type I interferon, respectively. The activation of NF-kBduring TLR7 and TLR9
signaling is initiated from the endosome whereas IRF7 activation is initiated from the lysosome-related organelle (LRO) after TLR7 and TLR9 are transported from
the endosome to this vesicle in a manner dependent on AP3. MyD88-dependent IRF7 activation in pDCs is mediated by activation of IRAK1, TRAF6, TRAF3, and
IKKa and is facilitated by IFN-inducible Viperin expressed in the lipid body. In cDCs and macrophages, TLR7 and TLR9 induce inflammatory responses by
activating NF-kB via MyD88 but fail to activate IRF7.
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activates two distinct signaling pathways: the ‘‘MyD88-depen-
dent’’ and ‘‘TRIF-dependent’’ pathways (Kawai and Akira,
2010). These two pathways have different kinetics. TLR4 initially
recruits TIRAP and MyD88. TIRAP localizes to the plasma
membrane via its interaction with PIP2, where it serves to bridge
the interaction between MyD88 and TLR4 upon LPS engage-ment (Barton and Kagan, 2009). MyD88 then recruits IRAKs,
TRAF6, and the TAK1 complex, leading to early-phase activation
of NF-kB andMAP kinases (Kawai and Akira, 2010). TLR4 is then
endocytosed and delivered to intracellular vesicles to form
a complex with TRAM and TRIF, which then recruits TRAF3
and the protein kinases TBK1 and IKKi, which catalyze the phos-
phorylation of IRF3, leading to the expression of type I IFNImmunity 34, May 27, 2011 ª2011 Elsevier Inc. 639
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TAK1 to mediate late-phase activation of NF-kB and MAP
kinases. The intracellular vesicles, into which TLR4 is delivered,
are small GTPase Rab11a-positive recycling endosomes (Huse-
bye et al., 2010). TLR4 accumulates around Escherichia coli-
containing phagosomes and triggers TRIF-dependent type I
IFN induction pathways. Thus, Rab11a specifically regulates
TLR4 mobilization from recycling endosomes to phagosomes,
a process necessary for TRIF-dependent induction of type I
IFN. Whereas activation of the TRIF-dependent pathway is suffi-
cient for type I IFN induction, activation of both the MyD88- and
TRIF-dependent pathways is required to drive robust NF-kB and
MAP kinase activation and the subsequent induction of
inflammatory cytokines. TAG, a splice variant of TRAM, binds
intracellular TLR4 to disrupt the TRAM-TRIF interaction, thus
terminating activation of the TRIF-dependent pathway (Pals-
son-McDermott et al., 2009).
TLR2-TLR1 and TLR2-TLR6, which signal through TIRAP and
MyD88, are expressed on the cell surface and are recruited to the
phagosome during phagocytosis of zymosan or Staphylococcus
aureus to induce the production of inflammatory cytokines.
However, there is some debate about whether TLR2 signaling
directly controls phagosome maturation. TLR2 is capable of
inducing type I IFN in CD11cCD11b+Ly6C+ inflammatory
monocytes infected with vaccinia viruses (Barbalat et al.,
2009). The induction of type I IFN by inflammatory mono-
cytes requires TLR2 internalization and is controlled by MyD88-
dependent activation of IRF3 and IRF7. Thus, inflammatory
monocytes activate unique MyD88-dependent pathways culmi-
nating in the activation of IRF3 and IRF7.
A recent report has indicated that TLR2 and TLR4 engagement
results in recruitment of mitochondria to macrophage phago-
somes and increased production of mitochondrial ROS that
has been implicated in mouse macrophage bactericidal activity
(West et al., 2011). TRAF6 is translocated to the mitochondria
upon bacteria infection, where it interacts with and promotes
ubiquitination of ECSIT, resulting in increased mitochondrial
and cellular ROS generation. Thus, mitochondria is a platform
that regulates TLR-induced bactericidal activity.
TLR7 and TLR9 signal through MyD88, which leads to induc-
tion of NF-kB-dependent inflammatory cytokine productions
by conventional DCs (cDCs) and macrophages. Notably, TLR7
and TLR9 are exclusively expressed in plasmacytoid DCs
(pDCs), which have the capacity to secrete vast amounts of
type I IFN rapidly in response to viral infection (Gilliet et al.,
2008; Reizis et al., 2011). The production of type I IFN by pDCs
after TLR7 and TLR9 engagement is also controlled in
a MyD88-dependent fashion. In pDCs, MyD88 forms a complex
with TRAF3, TRAF6, IRAK1, IKKa, IRF7, and other proteins such
as OPNi and Dock2 (Gotoh et al., 2010; Kawai and Akira, 2006).
IRF7 is phosphorylated by IRAK1 and IKKa contained within this
complex and translocates into the nucleus to regulate the
expression of type I IFN. It should be noted that the intracellular
trafficking and retention of the TLR9 signaling complex is thought
to determine the induction of inflammatory cytokines or type I
IFN. Retention of CpGDNA-TLR9 in the early endosomes boosts
MyD88 and IRF7 activation, resulting in IFN production (Honda
et al., 2005). A recent report showed that TLR9 activates two
signaling pathways within different intracellular compartments640 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.(Sasai et al., 2010). TLR9 initially traffics to the early endosomes
after CpG DNA stimulation, where it triggers MyD88-TRAF6-
dependent NF-kB activation and IL-12p40 production. TLR9
then traffics to the lysosome-related organelles (LRO), where it
incorporates TRAF3 to activate IRF7 and induces type I IFN.
AP3 specifically controls the trafficking in the latter case and is
required to assist TRAF3-IRF7 activation, rather than for
TRAF6-NF-kB activation. An IFN-inducing signaling complex
(MyD88-IRAK1-TRAF6-IRF7) is formed within lipid bodies by
the IFN-inducible Viperin protein (Saitoh et al., 2011). Viperin
targets IRAK1 for lysine 63-linked ubiquitination and activates
IRF7.
TLR5, which is expressed on the cell surface, signals through
MyD88 to induce inflammatory cytokine productions. A recent
study suggests that TLR5 in intestinal epithelial cells recruits
TRIF, in addition to MyD88, which leads to the activation of
NF-kB rather than IRF3 (Choi et al., 2010).
Detection of Bacterial PAMPs by TLRs
Bacteria consist of various PAMPs that are detected by TLRs.
Bacterial cell wall components are broadly recognized by cell
surface TLRs whereas nucleic acids are recognized by intracel-
lular TLRs. Lipopolysaccharide (LPS) from Gram-negative
bacteria is recognized by TLR4 (Akira et al., 2006). TLR2 recog-
nizes a wide variety of PAMPs of both Gram-positive and -nega-
tive bacteria and detects lipoproteins and peptidoglycans (PGN)
(present in both Gram-positive and Gram-negative bacteria), as
well as lipoteichoic acid fromGram-positive bacteria (Akira et al.,
2006). TLR2 forms heterodimers with TLR1, TLR6, or other cell
surface molecules such as Dectin-1 and CD36 to discriminate
between PAMP structures (Akira et al., 2006). The TLR2-TLR1
heterodimer recognizes triacylated lipopeptides from Gram-
negative bacteria whereas the TLR2-TLR6 heterodimer recog-
nizes diacylated lipopeptides from Gram-positive bacteria (Akira
et al., 2006). The flagellin protein component of the bacterial
flagella is recognized by TLR5 (Akira et al., 2006). TLR11 is highly
expressed in the kidney and bladder and is implicated in the
recognition of uropathogenic bacterial components although
a cognate PAMP has not been identified (Akira et al., 2006).
Bacterial genomic DNA is recognized by TLR9 (Akira et al.,
2006). TLR9 recognizes unmethylated 20-deoxyribo (cytidine-
phosphateguanosine) (CpG) DNA motifs that are frequently
present in bacteria and viruses but are rare in mammals.
However, it was shown that TLR9 senses the sugar-phosphate
backbone of DNA (Haas et al., 2008). TLR9 can recognize verte-
brate DNA if it is delivered to the endosomal compartment via
a transfection reagent. Thus, the location of DNA rather than
specific sequence, modification, or species origin of DNA is
important for the recognition by TLR9. Moreover, an interaction
between TLR9 and CpG-DNA is facilitated by host proteins
such as HMGB proteins and granulin, which are released to
the extracellular space by macrophages and DCs (Park et al.,
2011; Yanai et al., 2009). These bindings accelerate downstream
signaling. Bacterial RNA is also immunostimulatory. TLR7 is re-
ported to recognize RNA from Group B streptococci within the
lysosomal compartment (Mancuso et al., 2009).
There are redundancies in the recognition of bacterial PAMPs
between TLRs and other PRRs (Table 1). NLR members NOD1
(NLRC1), NOD2 (NLRC2), and NALP1 recognize degradation
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Immunity). NOD1 and NOD2 induce NF-kB- and MAP kinases-
dependent inflammatory responseswhereasNALP1 forms an in-
flammasome to induce the secretion of IL-1b via Caspase-1.
Other NLRs, Naip5, and IPAF detect flagellin of intracellular
bacteria that is delivered into cytosol through bacterial type IV
and type III secretion system and mediate IL-1b secretion
(Miao et al., 2007). The NALP3 inflammasomes are activated
by many TLR ligands although NALP3 itself may not directly
sense PAMPs. AIM2, which is not a member of NLR but forms
an inflammsome along with ASC and Caspase-1, senses dsDNA
in the cytoplasm and mediates innate immune responses to
Francisella tularensis and Listeria monocytogenes (Fernandes-
Alnemri et al., 2010; Rathinam et al., 2010).
Impact of TLRs on Innate ImmuneResponses toBacteria
The role of TLRs in in vivo bacterial infections has been studied in
mice deficient in individual TLRs. Salmonella typhimurium,
a Gram-negative bacterium that can replicate within macro-
phages, has at least four PAMPs detected by TLRs: lipoprotein
(TLR2), LPS (TLR4), flagellin (TLR5), and CpG-DNA (TLR9)
(Gerold et al., 2007). TLR4-deficient mice challenged with
S. typhimurium are more susceptible to infection than control
mice and show increased bacterial accumulation within the
mesenteric lymph nodes (Weiss et al., 2004). TLR2-TLR4
double-deficient mice are more susceptible than TLR4 single-
knockout mice, although TLR2 deficiency does not impair
survival (Weiss et al., 2004), suggesting that TLR2-mediated
responses are functional in the absence of TLR4. However,
TLR2-TLR4 double-deficient mice survive when infected with
low doses of bacteria, which may reflect natural rates of infec-
tion. TLR5 also plays a protective role subsequent to intraperito-
neal infection with S. typhimurium, intranasal infection with
Pseudomonas aeruginosa, and urinary tract infection with
E. coli (Andersen-Nissen et al., 2007; Feuillet et al., 2006).
However, TLR5 is deleterious in hosts orally infected with
S. typhimurium. TLR5-deficient mice show increased survival re-
sulting from decreased migration of bacteria from the intestinal
tract to the mesenteric lymph nodes (Uematsu et al., 2006).
Thus, TLR5 can be either beneficial or detrimental to the host,
depending on the bacterial dose and route of infection. Recently,
it was shown that TLR2-TLR4 double-knockout mice are highly
susceptible to oral infection with S. typhimurium, whereas
TLR2-TLR4-TLR9 triple-knockout mice, which have a more
severe phenotype in terms of cytokine induction than TLR2-
TLR4 double-knockout mice, are nevertheless less susceptible
to infection (Arpaia et al., 2011). In the absence of these three
TLRs, bacteria fail to upregulate the Salmonella pathogenicity
island 2 (SPI-2) genes that encode the proteins that are required
for survival within the Salmonella-containing vacuole (SCV) and
are, therefore, unable to replicate within macrophages. TLR
signaling leads to the acidification of the SCV, which is required
for SPI-2 induction. Thus, S. typhimurium may use TLRs as
signals that support the expression of their own virulence genes,
which are required for growth and systemic infection.
S. aureus is a Gram-positive bacterium that contains several
TLR PAMPs. The TLR2-TLR6 heterodimer recognizes lipopro-
tein and lipoteichoic acid. TLR2-deficient mice show an
increased bacterial burden and succumb after systemic infec-tion with S. aureus (Takeuchi et al., 2000). Moreover, they
also show an increased bacterial burden and disease severity
after nasal, cutaneous, and corneal infection (Gerold et al.,
2007), suggesting that TLR2-mediated recognition of lipopro-
teins induces a protective response to S. aureus. In contrast,
in a brain abscess model, there was no difference on bacterial
burden, survival, and neutrophil infiltration between TLR2-defi-
cient and control mice (Miller et al., 2006). MyD88-deficient
mice are more susceptible to infection than TLR2-deficient
mice in various infection models (Miller et al., 2006; Takeuchi
et al., 2000), suggesting a contribution by other TLRs and/or
members of IL-1 receptor family. Indeed, IL-1 receptor-defi-
cient mice are protected against S. aureus-induced sepsis
and show reduced cytokine production and impaired neu-
trophil recruitment in cutaneous infection models (Verdrengh
et al., 2004). Therefore, both IL-1 receptor and TLR2 signaling
are coupled to induce protective immune responses against
S. aureus infection.
Cooperation between TLRs and Other PRRs
in the Regulation of Innate and Adaptive Immune
Responses to Mycobacterium Infection
Tuberculosis can be acquired by inhalation of Mycobacterium
tuberculosis (Mtb) in aerosols and dust. Mtb is initially internal-
ized into the phagosomes of alveolar macrophages (AM), where
theymultiply. Initial infection byMtb is probably sensed by TLR2,
TLR4, and TLR9, upregulating the transcription of inflammatory
cytokines such as IL-1b, IL-12, TNF-a, and IL-6, which control
the infection (Gerold et al., 2007; Saiga et al., 2011). MyD88-defi-
cient mice are extremely susceptible to Mtb infections associ-
ated with increased bacterial burden, with a concomitant reduc-
tion of IFN-g, IL-12, TNF-a, and NOS2 production (Saiga et al.,
2011). This suggests that TLR-mediated recognition of Mtb is
critical for innate responses to Mtb. However, there are conflict-
ing results regarding the in vivo importance of individual TLRs in
protective responses to Mtb. Some reports indicate that mice
deficient for TLR2, TLR4, or TLR9 exhibit no, or only minor,
susceptibility to low-dose Mtb infection whereas others suggest
that TLR2- and TLR9-deficient mice are highly susceptible to
infection by high-dose Mtb (Saiga et al., 2011). Moreover,
TLR4-deficient mice show increased susceptibility (Saiga et al.,
2011). However, a study with TLR2-TLR4-TLR9 triple-knockout
mice infected with Mtb found controlled replication of Mtb in
the lung, similar to that observed in control mice (Ho¨lscher
et al., 2008). Thus, the role of individual TLRs that recognize
Mtb PAMPs may be largely redundant in mediating protective
immune responses to low-dose aerosol Mtb infection. In addi-
tion to the innate immune responses that are critical for the initial
defense against Mtb infection, the adaptive immune response
also has an important role to play against chronic infections.
Antigen-specific Th cells that produce IFN-g enhance the killing
activity of infected macrophages. Notably, although MyD88-
deficient mice are highly susceptible to infection and exhibit an
increased bacterial burden, the induction of Th1 cell develop-
ment as well as macrophage effecter responses are unimpaired
(Saiga et al., 2011). Thus, induction of adaptive immune
responses to Mtb may be mediated by PRRs other than TLRs.
Alternatively, other PRRs may compensate for TLR-dependent
Th1 cell development.Immunity 34, May 27, 2011 ª2011 Elsevier Inc. 641
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nition of Mtb. Impaired cytokine induction by macrophages and
DCs after infection byMtb is observed inmice deficient for NOD2
(Saiga et al., 2011). NOD2 acts synergistically with TLR2 to
induce inflammatory cytokine production after Mtb infection.
However, NOD2 single- and NOD2-TLR2 double-knockout
mice are able to control Mtb replication and are only as suscep-
tible to virulent Mtb infection as control mice (Gandotra et al.,
2007). Mice deficient in IL-1b or IL-1 receptor have high mortality
(similar to MyD88-deficient mice) (Fremond et al., 2007), which
suggests that IL-1 receptor signaling plays a dominant role in
determining the phenotype of MyD88-deficient mice. Notably,
IL-1b levels in the lungs of Mtb-infected mice are increased in
MyD88-, Caspase-1-, and ASC-deficient mice, and Caspase-
1- and ASC-deficient mice are less susceptible to Mtb infection
than IL-1b-deficient mice (Mayer-Barber et al., 2010; McElvania
Tekippe et al., 2010). Furthermore, dispensable role for Cas-
pase-1 and NALP3 is also reported although ASC is partially
involved (McElvania Tekippe et al., 2010). These findings
suggest that there are as yet uncharacterized innate pathways
that control IL-1b release during Mtb infection.
Certain CLRs recognize mycobacterial components and
induce inflammatory cytokines. These include the mannose
receptor, DC-SIGN, Dectin-1, and Mincle, although their
cognate PAMPs have not yet been identified (Geijtenbeek and
Gringhuis, 2009; Marakalala et al., 2010). The requirement for
these CLRs in the control of Mtb infections in vivo varies between
various studies, principally because of differences in the cell
types or mycobacterial species used. However, it appears that
CARD9 plays a critical role. CARD9 was originally identified as
an essential molecule involved in antifungal immunity (Gross
et al., 2006). Subsequent studies show that CARD9 is also
involved in signaling through multiple PRRs, including Dectin-
1, TLRs, NOD2, and RIG-I (Mo´csai et al., 2010; Poeck et al.,
2010). Thus, CARD9 may converge the signaling from multiple
PRRs that mediate recognition of Mtb. CARD9-deficient macro-
phages and DCs show reduced production of inflammatory
cytokines after infection with Mtb, indicating that CARD9 medi-
ates innate immune responses to Mtb. CARD9-deficient mice
challenged with virulent Mtb rapidly succumb to systemic
inflammatory diseases associated with augmented cell death
in the lung and enhanced recruitment of granulocytes. Failure
to suppress excessive inflammation in the absence of CARD9
is most probably due to reduced production of IL-10 (Dorhoi
et al., 2010). Thus, CARD9 signaling is critical for the control of
Mtb infection. However, it is notable that CARD9 deficiency
does not affect T cell responses to Mtb (Dorhoi et al., 2010).
Recognition of Viral Nucleic Acids through TLRs
Viral nucleic acids act as PAMPs and are recognized by multiple
TLRs. TLR3, TLR7, TLR8, and TLR9 are involved in the recogni-
tion of viral nucleotides such as double-stranded RNA (dsRNA)
(TLR3), single-stranded RNA (ssRNA) (TLR7-TLR8), and DNA
(TLR9) (Blasius and Beutler, 2010). The hallmark of these nucleic
acid-sensing TLRs is that they potently promote the production
of type I IFN, in addition to the other inflammatory cytokines that
are induced by all TLRs.
TLR3 was originally identified to recognize a synthetic analog
of dsRNA polyinosinic-polycytidylic acid (poly(I:C)). TLR3 also642 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.recognizes genomic RNA from dsRNA viruses (including reovi-
ruses) and dsRNA produced during replication of ssRNA viruses
(such as influenza A virus [IAV], encephalomyocarditis virus
[EMCV], and West Nile virus [WNV]) and dsDNA viruses (herpes
simplex virus 1 [HSV-1] and murine cytomegarovirus [MCMV])
(Akira et al., 2006; Blasius and Beutler, 2010).
TLR7 and human TLR8 mediate the recognition of ssRNA
derived from ssRNA viruses and synthetic antiviral imidazoqui-
noline components (Akira et al., 2006; Blasius and Beutler,
2010). TLR7 recognizes ssRNA derived from HIV or influenza
virus and synthetic polyuridine ssRNA. TLR7 and TLR9 are
both highly expressed by pDCs (Akira et al., 2006; Blasius and
Beutler, 2010; Gilliet et al., 2008; Reizis et al., 2011). Induction
of type I IFN by pDCs occurs independently of the replication
of enveloped viruses such as IAV. TLR7 is likely to engage viral
RNA within endosomal compartments that are delivered subse-
quent to virus uptake (Blasius and Beutler, 2010). Moreover,
pDCs can recognize replicating viruses, such as VSV, that enter
the cytoplasm. The delivery of cytosolic viral RNA to the lyso-
some via autophagy, a process involving lysosomal degradation
of cellular organelles or pathogens, results in TLR7-mediated
recognition and activation of signaling (Lee et al., 2007). TLR8
is expressed in various tissues, with the highest expression in
monocytes.
TLR9 recognizes the viral DNA of DNA viruses that contain
sequences rich in CpG-DNA motifs. TLR9 is involved in recogni-
tion of HSV-1, HSV-2, and MCMV (Akira et al., 2006; Blasius and
Beutler, 2010; Gilliet et al., 2008; Reizis et al., 2011). Type I IFN
production by pDCs after infection by these viruses is completely
dependent upon TLR9, suggesting that TLR9 serves as a sensor
for DNA viruses in pDCs.
Sensing of Viral Infections by TLR2, TLR4, and TLR13
Cell-surface TLRs such as TLR2 and TLR4 recognize viral prod-
ucts. TLR4 recognizes the fusion protein from RSV and induces
the production of inflammatory cytokines (Akira et al., 2006).
TLR4-deficient mice show reduced viral clearance, accompa-
nied by low levels of infiltrating mononuclear cells and reduced
production of IL-12. The envelope protein of mouse mammary
tumor virus (MMTV) is also recognized by TLR4 (Akira et al.,
2006). MMTV enhances the expression of its entry receptor to
facilitate viral entry via TLR4. Thus, MMTVmay subvert host anti-
viral responses via its interaction with TLR4. TLR4-deficient mice
are protected from acute lung injury caused by inactivated H5N1
avian influenza virus. TLR4-mediated sensing of oxidative stress
is considered to contribute to inflammation (Imai et al., 2008).
TLR2 senses viral components, such as measles virus hemag-
glutinin protein, human CMV, and HSV-1, and induces inflamma-
tory cytokines (Akira et al., 2006). In addition, TLR2 is capable of
inducing type I IFN in a cell type-specific manner. When stimu-
lated with inactivated vaccinia virus, inflammatory monocytes
produce type I IFN via TLR2, which is in contrast tomacrophages
and other types of DCs where TLR2 induces inflammatory
cytokines, but not type I IFN (Barbalat et al., 2009). Moreover,
induction of TLR2-dependent type I IFN does not require
nucleic acids. TLR13 is localized intracellularly and interacts
with UNC93B1 (Shi et al., 2011). TLR13 is implicated in the
recognition of vesicular stomatitis virus (VSV) for the induction
of type I IFN.
Figure 2. Interplay between TLRs and RLRs
during Virus Infection
AM recognize RNA viruses such as NDV via RLRs.
pDCs are able to produce type I IFN when the first
line of RLR-mediated defensive responses in AM is
suppressed or disrupted by the virus (top). HCV is
recognized by TLR3 and RIG-I in hepatocytes.
However, HCV evades type I IFN responses by
expressing viral NS3-NS4A protease, which
cleaves TRIF and IPS-1. HCV RNA is delivered
from infected hepatocytes to the pDCs that are
migrated into the liver upon direct cell-to-cell
contact, which triggers type I IFN production via
TLR7. The RNA may be delivered through auto-
phagosomes or exosomes (bottom).
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Although TLR3 triggers the production of type I IFN and inflam-
matory cytokines required for eliminating viruses, the in vivo
requirement for TLR3 for protection against infection is contro-
versial. TLR3-deficient mice are more susceptible than control
mice to MCMV infections, probably because of reduced produc-
tion of type I IFN, IL-12p40, and IFN-g and a reduction in NK and
NKT cell activation (Tabeta et al., 2004). TLR3-mediated IFN-g
but not type I IFN signaling is necessary for protection against
infection by coxsackievirus group B serotype 3 (Negishi et al.,
2008). Also, TLR3-deficient mice are more susceptible to infec-
tion with virulent WNV (Daffis et al., 2008). Early viral entry into
the CNS and the virus titer in the peripheral tissues are both
increased in TLR3-deficient mice. These findings indicate that
TLR3-mediated RNA recognition promotes protective immunity.
However, there are reports indicating that TLR3 contributes to
pathogenesis rather than protection. TLR3-deficient mice show
increased survival rates after WNV infection (Wang et al.,
2004). The production of inflammatory cytokines in the periphery
is also decreased in TLR3-deficient mice, resulting in inhibition of
viral entry into the brain because of decreased blood-brain
barrier permeability. TLR3-deficient mice infected with IVA also
exhibit increased survival despite the higher viral loads in the
lung (Le Goffic et al., 2006). The increased survival is probably
due to the abrogation of the IVA-induced overproduction of
cytokines, which is detrimental to the host. Moreover, it has
been reported that TLR3 is not necessary for antiviral responses
because TLR3 deficiency does not affect survival or CD4+ T andImmunityCD8+ T cell responses after infection with
MCMV, reoviruses, lymphocytic chorio-
meningitis virus, and VSV (Edelmann
et al., 2004).
Interplay between TLRs and Other
PRRs during Viral Infection
Infection by RNA viruses is sensed by
TLR7 and RLRs, both of which induce
type I IFN. Ex vivo experiments indicate
that type I IFN production by pDCs
subsequent to RNA viruses such as IAV,
VSV, and Newcastle disease virus (NDV)
relies on TLR7, whereas production by
cDCs, macrophages, and fibroblasts
depends on RIG-I (Akira et al., 2006).Interplay between TLRs and RLRs in different cell types during
viral infection plays an important role in antiviral responses.
When mice were intranasally infected with NDV, pDCs were
not the major source of type I IFN. Rather, AM and cDCs
produced type I IFN via RLRs (Kumagai et al., 2007). Interest-
ingly, pDCs are capable of producing type I IFN in the absence
of functional AM, suggesting that pDCs play a dominant role
when the first line of AM-mediated defensive responses is dis-
rupted (Kumagai et al., 2007). Given that many viruses have
evasion mechanisms that suppress RLR signaling (i.e., NS1 of
IAV suppresses RIG-I signaling), pDCsmay function as a backup
for antiviral responses when RLR signaling is suppressed by
viruses (Figure 2).
Hepatitis C virus (HCV) is recognized by TLR3 and RIG-I.
However, HCV evades type I IFN responses by expressing viral
NS3-NS4A protease, which cleaves TRIF and IPS-1 (Horner
and Gale, 2009; Lemon, 2010; Rehermann, 2009). Thus, type I
IFN production in infected hepatocytes is suppressed. However,
HCV induces robust type I IFN production by pDCs, which infil-
trate the liver during infection. Production of type I IFN by pDCs
in the liver is dependent on direct cell-to-cell contact with in-
fected hepatocytes but is independent of the uptake of viral
particles by the pDCs (Figure 2; Takahashi et al., 2010). Thus,
viral RNA in the infected hepatocytes is likely to trigger type I
IFN production by pDCs. When a replication-defective RNA is
transfected into pDCs, type I IFN is induced in TLR7-dependent
manner. Collectively, HCV RNA is delivered from infected hepa-
tocytes to the pDCs upon direct cell-to-cell contact, which34, May 27, 2011 ª2011 Elsevier Inc. 643
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the RNA is transported via vesicle transfer through autophago-
somes or exosomes. It is reported that the ability of pDCs from
HCV-infected patients to induce type I IFN is normal although
their number of pDCs is reduced (Kanto et al., 2004; Shiina
and Rehermann, 2008). A greater understanding of the mecha-
nisms underlying the function of liver pDCs in the regulation of
HCV infection is required.
Recognition of Fungal PAMPs by TLRs
Invasive Candida infection is life threatening in immunocompro-
mised patients. The innate immune recognition ofCandida infec-
tion by DCs induces the production of an array of inflammatory
cytokines and the upregulation of costimulatory molecules that
support the differentiation of naive T cells into Th1, Th2, Th17,
and Treg cells. In a mouse model of Candida albicans infection,
Th1 and Th17 cell responses are crucial for protection against
infection whereas Th2 and Treg cell responses suppress innate
immune responses that are deleterious to the host. Candida
spp. contains multiple PAMPs such as b-glucan, chitin, mannan,
proteins, and nucleic acids, which are recognized by at least five
TLRs (TLR2, TLR4, TLR6, TLR7, and TLR9) as well as CLRs and
NLRs (Netea and Maro´di, 2010; Romani, 2011).
A general role of TLR- and/or IL-1 receptor family-mediated
responses in host defense against C. albicans is reported in
studies on MyD88-deficient mice that are highly susceptible to
infection (Bellocchio et al., 2004). However, there are conflicting
reports regarding the role of individual TLRs in the host innate
and adaptive immune responses to Candida spp. Phospholipo-
mannan from C. albicans stimulates DCs and macrophages to
produce TNF-a, IL-1b, and IL-10 via TLR2 (Netea and Maro´di,
2010), leading to the generation of Th2 and Treg cells. TLR2-defi-
cient mice are more resistant to lethal disseminated candidiasis
than control mice, and this is accompanied by decreased
production of IL-10 and increased production of IFN-g and
IL-12 (Netea et al., 2004; Sutmuller et al., 2006). Thus, TLR2-
mediated recognition of Candida spp. may be rather deleterious
to the host. However, other studies suggest protective or
dispensable role of TLR2 in antifungal responses in vivo (Netea
and Maro´di, 2010). TLR2-deficient mice produce lower levels
of TNF-a and chemokines and are more susceptible to dis-
seminated candidiasis than control mice. Moreover, TLR2-defi-
cient mice are not protected against a second challenge with
C. albicans hyphae after sublethal infection with virulent
C. albicans (Bellocchio et al., 2004). Although TLR2-deficient
mice show lower levels of antibody production than control
mice after challenge with low-virulence Candida spp., like the
control mice they are protected against rechallenge of virulent
C. albicans (Netea and Maro´di, 2010). The TLR6-TLR2 hetero-
dimer recognizes zymosan, and TLR6 deficiency modestly
impairs cytokine production afterC. albicans infection. However,
TLR6-deficient mice do not show increased susceptibility (Netea
and Maro´di, 2010).
TLR4 recognizes mannans expressed by Saccharomyces
cerevisiae and C. albicans. Short, linear O-linked mannans are
recognized by TLR4, resulting in the production of cytokines
such as TNF-a (Netea and Maro´di, 2010). The role of TLR4 in
host defense against C. albicans is complicated. It was reported
that TLR4-defective C3H/HeJ mice were more susceptible to644 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.C. albicans infection than control mice, and this was associated
with decreased production of the chemokines by macrophages
and impaired recruitment of neutrophils (Netea and Maro´di,
2010). Furthermore, TLR4-deficient mice are susceptible to rein-
fection with Candida hyphae after priming with low-virulence
Candida yeast (Netea and Maro´di, 2010). By contrast, other
studies indicate that TLR4 deficiency does not influence suscep-
tibility to Candida yeast and that TLR4-deficient mice survive
longer than control mice when systemically infected with
Candida hyphae (Netea and Maro´di, 2010).
In addition to cell-surface TLRs, intracellular TLRs such as
TLR7 and TLR9 participate in the recognition of fungal nucleic
acids that are released into TLR-containing vesicles during
digestion by phagocytes. Fungal DNA induces the production
of inflammatory cytokines by DCs via TLR9 (Netea and Maro´di,
2010; Romani, 2011). CD4+ T cells from TLR9-deficient mice
show higher levels of IL-4 and lower levels of IFN-g production
after challenge with C. albicans than those from control mice,
suggesting that the TLR9-dependent pathway skews T cells
toward Th1 cell polarization. However, TLR9-deficient mice
are protected against rechallenge of virulent C. albicans (Belloc-
chio et al., 2004). A protective role for TLR9 is suggested by
a study with a mouse model of vaccination. Vaccination of
mice with Aspergillus proteins plus a TLR9 agonist enhances
Th1 cell responses and protection against aspergillosis (Bozza
et al., 2002).
Challenging cDCs with Candida spp. triggers type I IFN
release, which is abrogated by TLR7 deficiency (Bourgeois
et al., 2011). This induction requires phagocytosis of Candida
spp. Thus, Candida spp. RNA is likely to be sensed by TLR7.
The Candida burden is decreased in mice lacking type I IFN
receptor (IFNAR). A significant increase in the incidence of
splenomegaly is observed after Candida infection in IFNAR-
deficient mice. Therefore, Candida infection-induced type I
IFN production by cDCs may suppress the inflammatory
responses that are required for host defensive responses. By
contrast, another study shows that mice lacking type I IFN
signaling challenged intravenously with C. albicans die earlier
because of a failure of controlling replication, suggesting that
type I IFN production by cDCs is protective in this case (Biondo
et al., 2011). Collectively, it appears that individual TLRs elicit
different but overlapping immune responses against Candida
infection.
Collaboration between TLRs and Other PRRs
in the Regulation of Antifungal Immunity
Certain TLRs cooperate with members of CLRs to mount anti-
fungal immunity (Netea and Maro´di, 2010; Romani, 2011). Dec-
tin-1 recognizes b-1,3-linked glucan and mediates phagocytosis
of fungus by DCs. Dectin-1 triggers signaling pathways involving
the Syk tytosine kinase and CARD9, which leads to the produc-
tion of IL-2, IL-10, and other cytokines. This pathway drives Th17
cell responses and is required for protection against Candida
infection in vivo although difference of C. albicans strains or
knockout background may influence a requirement of this
pathway in host defense (Netea and Maro´di, 2010; Romani,
2011). The importance of CARD9 against C. albicans infection
in vivo is also shown in humans and mice (Gross et al., 2006;
Glocker et al., 2009). Notably, dectin-1 collaborates with TLR2
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C. albicans and zymosan (Goodridge and Underhill, 2008). Ga-
lectin 3 and Mannose receptor are involved in supporting
TLR2-mediated innate and Th cell responses to C. albicans (Ne-
tea and Maro´di, 2010; Romani, 2011). In addition to CLRs,
NALP3 is also involved in antifungal responses. The NALP3 in-
flammasome is activated by infection by C. albicans and
S. cereviciae, and the activation of Caspase-1 and the produc-
tion of IL-1b triggered by these fungi are dependent on NALP3
(Gross et al., 2009; Hise et al., 2009; Joly et al., 2009; Kumar
et al., 2009). IL-1b is thought to mediate neutrophil recruitment
and the generation of ROS, and IL-1 receptor-deficient mice
consistently show increased susceptibility to disseminated
candidiasis. NALP3-deficient mice are more susceptible to
Candida infections than control mice. Fungal b-glucans are
responsible for NALP3 inflammasome-dependent IL-1b release,
which requires phagocytosis and Syk activation. Thus, IL-1b
production by b-glucans may be regulated by two steps: one
involving the dectin-1-dependent induction of pro-IL-1b expres-
sion and the other involving NALP3-mediated processing of pro-
IL-1b to mature IL-1b. Moreover, it was shown that ATP drives
the NALP3 inflammasome activation in response to zymosan
(Lamkanfi et al., 2009).
Recognition of Protozoa and Parasites by TLRs
Components of protozoan parasites such as Trypanosoma
cruzi, Trypanosoma brucei, Toxoplasma gondii, Leishmania
major, and Plasmodium falciparum are sensed by TLRs (Gazzi-
nelli and Denkers, 2006). T. cruzi-derived glycosylphosphatidy-
linositol (GPI) anchors activate macrophages to induce inflam-
matory cytokines through TLR2 (Gazzinelli and Denkers,
2006). In addition, free GPI anchors (glycoinositolphospholipids
containing ceramide) derived from T. cruzi trigger the produc-
tion of chemokines via TLR4 (Gazzinelli and Denkers, 2006).
Similarly, TLR2 and/or TLR4 are involved in the recognition of
GPI anchors from T. gondii, L. major, and P. falciparum (Gazzi-
nelli and Denkers, 2006). In addition to GPI anchors, structural
proteins and genomic DNA are also recognized by TLRs (Gazzi-
nelli and Denkers, 2006). The T. cruzi-derived protein Tc52,
which is related to the thiol-disulfide oxidoreductase family, trig-
gers inflammatory cytokine induction by DCs via TLR2. The
soluble fraction of T. gondii tachyzoites contains a potent
inducer for IL-12 known as soluble Toxoplasma antigen. This
is mediated by a profilin-like molecule (a small ubiquitous
protein with a known actin-binding protein that is implicated in
parasite motility and invasion), which is recognized by mouse
TLR11 (Yarovinsky et al., 2005). Human TLR11 is, however,
nonfunctional because of the presence of a stop codon in the
gene. Notably, TLR9 is involved in the recognition of the heat-
labile non-DNA fractions and hemozoin derived from
P. falciparum (Coban et al., 2005). Hemozoin is an insoluble
crystal generated as a by-product of the detoxification process
after parasitic digestion of host hemoglobin and induces the
production of inflammatory cytokines and type I IFN by DCs
via TLR9. TLR9-deficient mice display partial resistance to lethal
infection by the rodent malaria parasite Plasmodium yoelii re-
sulting from impaired Treg cell activation (Hisaeda et al.,
2008). Thus, TLR9 may be targeted by malaria parasites for
evasion.Role of TLRs in Protection against Protozoa
and Parasites
Mice deficient for MyD88 are highly susceptible to infection with
L. major, T. brucei, T. cruzi, Plasmodium berghei, and T. gondii,
and this is associated with decreased production of the Th1
cytokines IFN-g and IL-12 (Gazzinelli and Denkers, 2006). This
indicates that TLR-mediated recognition of protozoan parasites
is critical for immediate activation of the innate immune system
and the consequent induction of Th1 cells. Micewith a deficiency
of MyD88 specifically in DCs show defective IL-12 production
and compromised Th1 cell responses after T. gondii infection
(Hou et al., 2011). Furthermore, MyD88 signaling in DCs, but
not neutrophils or macrophages, is required for host defense
during acute infection by T. gondii before Th1 cell responses
can be initiated. Thus, MyD88 signaling in DCs is critical for
IL-12-dependent innate and adaptive immune responses to
T. gondii in vivo.
However, in contrast to a critical role of MyD88 in survival,
inactivation of TLR2, TLR4, or TLR9 has no (or only a modest)
effect on survival or immune responses during infection with
L. major, T. brucei, T. cruzi, P. berghei, P. falciparum, and
T. gondii, suggesting that multiple TLRs orchestrate the protec-
tive responses (Adachi et al., 2001; Bafica et al., 2006; Coban
et al., 2007; Kropf et al., 2004; Mun et al., 2003; Ropert and
Gazzinelli, 2004). Indeed, TLR2 and TLR9 double deficiency
in mice results in increased susceptibility to T. cruzi infection,
which is comparable to MyD88-deficient mice. TLR11-deficient
mice are more susceptible to T. gondii infection, with a concom-
itant decrease in IL-12 and IFN-g production; however, they are
not as susceptible as MyD88-deficient mice (Bafica et al.,
2006), suggesting a partial involvement of TLR11 in mounting
protective Th1 cell responses. It is reported that pDCs from
mice infected with T. gondii are able to produce IL-12 and
present antigen to prime naive CD4+ T cells through TLR11
(Pifer et al., 2011), suggesting an unexpected role for pDCs in
the development of adaptive immune responses to nonviral
pathogens.
Recently, it was shown that mice with a loss of functional
UNC93B1, which fail to respond to TLR3, TLR7, or TLR9
agonists, show decreased IL-12 production by DCs and are
highly susceptible to infection with T. gondii although deficiency
in TLR3, TLR7, or TLR9 alone does not influence susceptibility
(Melo et al., 2010; Pifer et al., 2011). This suggests a combined
role for nucleic acid-sensing TLRs in host resistance to
T. gondii. Notably, TLR11 is found to be expressed in the ER
along with UNC93B1. Thus, UNC93B1 is likely to regulate not
only nucleic acid-sensing TLRs but also protein-sensing
TLR11 in intracellular compartments to establish antiparasitic
immunity.
Role of TLRs in Shaping Adaptive Immune Responses
The activation of innate immunity is essential for instructing
antigen-specific adaptive immune responses. Indeed, TLR
ligands such as monophosphoryl lipid A (TLR4 ligand), CpG-
DNA (TLR9 ligand), and imidazoquinolines (TLR7 ligand) are
currently developing for use as vaccine adjuvant against infec-
tious diseases, allergy, and tumors. TLRs are mainly expressed
in antigen-presenting cells such as DCs, macrophages, and B
cells. Careful analyses demonstrated that individual TLRs areImmunity 34, May 27, 2011 ª2011 Elsevier Inc. 645
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by CD8a+ DCs in mice and CD141 (BDCA3)+ DNGR-1
(CLEC9A)+ DCs in humans which have high phagocytic activity
(Edwards et al., 2003; Villadangos and Shortman, 2010). These
cells mount efficient CD8+ T cell responses when they engulf
either dsRNA-loaded cells or virally infected cells and trigger
DC maturation and the presentation of viral antigen on MHC
class I molecules, both of which stimulate CD8+ T cell responses
(Schulz et al., 2005). This process, referred to as cross-priming,
is abrogated by TLR3 deficiency, indicating a critical role of
TLR3 in mounting virus-specific CD8+ T cell responses. TLR5
is highly expressed in CD11c+CD11b+ lamina propria DCs in
the small intestine, which have properties to promote Th1 and
Th17 cell differentiation as well as the differentiation of naive B
cells into IgA-producing plasma cells in response to flagellin (Ue-
matsu et al., 2008). pDCs selectively express TLR7 and TLR9 to
recognize viral nucleic acids. TLR7-mediated type I IFN produc-
tion by pDCs is essential for both Th1 cell polarization and anti-
body production when mice are given inactivated whole-influ-
enza vaccine (Koyama et al., 2010). Thus, TLR signaling in
DCs can instruct adaptive immune responses both ex vivo and
in vivo.
However, TLRs and other PRRs often share the same adjuvant
for recognition and activation of immune responses. These
include poly(I:C) (recognized by TLR3 and MDA5), flagellin
(recognized by TLR5 and IPAF/Naip5), and hemozoin (recog-
nized by TLR9 and activates the NALP3 inflammasome). When
poly(I:C) was given along with antigen into mice, antigen-specific
antibody production and the differentiation of CD4+ and CD8+
T cells were both abrogated in mice lacking both TRIF and
IPS-1 (Kumar et al., 2008). Furthermore, the recognition of
poly(I:C) by MDA5 expressed by DCs, monocytes, and stromal
cells and the induction of type I IFN are required to support
Th1 cell responses (Longhi et al., 2009). Together, the interplay
between TLR3 and RLRs is required for robust adaptive immune
responses induced by poly(I:C).
The ability of flagellin to promote innate and adaptive immune
responses was studied with mice deficient for TLR5, IPAF, or
both (Vijay-Kumar et al., 2010). The production of CXCL1 after
in vivo injection of flagellin is totally dependent on TLR5 whereas
the production of IL-18, which is generated by the inflamma-
some, is regulated by IPAF. However, TLR5 or IPAF deficiency
did not abrogate ability of mice to generate antigen-specific anti-
bodies whereas TLR5 and IPAF double-deficient mice showed
reduced antibody titer, indicating that both TLR5- and IPAF-
mediated flagellin recognitions are required in the adjuvanticity.
Notably, MyD88-deficient mice that are unresponsive to various
TLR ligands and IL-1b and IL-18 generated by the inflammasome
are capable of mounting antibody responses although the titer is
slightly reduced. These findings suggest that signaling compo-
nents other than MyD88 in TLR5 and IL-1 receptor family
members contribute to the regulation of humoral responses. A
recent report has implicated that expansion of flagellin-specific
CD4+ T cells requires the expression of TLR5 by DCs (Letran
et al., 2011). However, MyD88 was unexpectedly dispensable
for the generation of CD4+ T cells. Thus, TLR5 may function as
endocytoic receptor for flagellin in DCs that enhance presenta-
tion of flagellin-derived peptide to CD4+ T cells through
MyD88-independent pathway.646 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.In a vaccinationmodel, the adjuvant effects of synthetic hemo-
zoin such as antigen-specific antibody production are indepen-
dent on TLR9, but totally dependent on MyD88, suggesting the
involvement of other TLRs and/or IL-1 receptors in shaping
adaptive immunity (Coban et al., 2010). Moreover, it is possible
that the NALP3 inflammasome is also involved, because hemo-
zoin is able to activate the NALP3 inflammasome to induce
secretion of IL-1b, which eventually activatesMyD88-dependent
signaling pathways (Dostert et al., 2009; Griffith et al., 2009; Shio
et al., 2009).
The essential role of TLR7 in shaping adaptive immunity
against IAV infection has been studied. In a mouse model of
IAV infection, Th1 cell responses and the production of virus-
specific total IgG, IgG2a, and IgG2c were reduced in TLR7-
and MyD88-deficient mice, while that of IgG1 was increased
(Koyama et al., 2007). Moreover, TLR7 is critical for Th1 cell
polarization and antibody production when mice are given inac-
tivated whole-influenza vaccine (Koyama et al., 2010). Thus,
both Th1 cell responses and antibody production are regulated
by TLR7 in vivo. It is notable that CTL induction occurs indepen-
dently via TLR7 andRLRs (Koyama et al., 2007). Multiple types of
innate cells in the lung are implicated in mediating the generation
of CTLs, although the innate immune pathways that control CTL
activation in these cells remain uncharacterized. IAV induces IL-
1b release through NALP3 inflammasome (Ichinohe, 2010), sug-
gesting the possibility that NALP3 participates in this pathway. In
contrast to studies indicating a protective role for TLR7, others
report that TLR7 is not necessary in shaping antibody responses
(Seo et al., 2010). The differences between these studies may be
due to the different experimental conditions used, such as virus
strains and infection protocol.
In contrast, several adjuvants do not contain TLR agonists
but do effectively induce antigen-specific adaptive immune
responses. For example, humoral and Th1 cell responses
induced by DNA vaccines, which have antigenic sequences
as well as elements that enhance innate immune response,
do not require TLR9, RLRs, or DAI but do require STING and
TBK1 (Ishii et al., 2008; Barber, 2011), suggesting that uniden-
tified DNA sensors that signal through STING and TBK1 may
play critical role. Adjuvant effects of alum such as Th2 cell-
biased humoral responses are independent on TLRs but are
regulated by the NALP3 inflammasome (Spreafico et al.,
2010). However, the contribution of the NALP3 inflammasome
in the adjuvanticity of alum is controversial (Spreafico et al.,
2010). Mycobacterial glycolipid PAMP treharose-6,6-dimyco-
late (TDM, also known as cord factor) is used as an adjuvant
and is recognized by Mincle. Inflammatory cytokine production
and Th1 and Th17 cell responses to TDM are reduced in Mincle-
deficient mice (Ishikawa et al., 2009; Schoenen et al., 2010).
CARD9 and Syk are also involved in this pathway. Thus, the
Mincle-Syk-CARD9-dependent pathway is critical in initiating
innate and adaptive immunity triggered by mycobacterial glyco-
lipid (Werninghaus et al., 2009). Conventional adjuvants such as
Freund’s complete adjuvant, Freund’s incomplete adjuvant,
and monophosphoryl-lipid A/trehalose dicorynomycolate adju-
vant drive effective antibody responses in the absence of TLR
signaling even though they contain TLR ligands (Gavin et al.,
2006), suggesting dispensable role of TLRs in induction of
adaptive immunity.
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Molecules in Human Immunodeficiency
After the discovery of TLRs, much progress has been made in
our understanding that the mutations of genes involved in the
regulation of innate immunity is linked to primary immunodefi-
ciencies (PIDs) in humans (Casanova et al., 2011). Currently,
five PIDs with impaired TLR signaling pathways have been
described: autosomal-recessive MyD88, IRAK4, and UNC93B1
deficiency and autosomal-dominant TLR3 and TRAF3 deficiency
(Casrouge et al., 2006; Pe´rez de Diego et al., 2010; Picard et al.,
2003; von Bernuth et al., 2008; Zhang et al., 2007). MyD88 and
IRAK4 deficiencies predispose patients to recurrent life-threat-
ening pyogenic bacterial infections, including invasive pneumo-
coccal diseases, in childhood associatedwith poor inflammatory
responses. The clinical symptoms of these patients are
improved with age, suggesting that adaptive immunity or other
PRRs may compensate the deficiency of TLR signaling. TLR3,
UNC93B1, or TRAF3 deficiency specifically predisposes
patients to herpes simplex virus-1 encephalitis (HSE). Although
TRAF3 is involved in signaling through TNF receptor family
members, a clinical phenotype of TRAF3 deficiency is probably
a result from the impaired TLR3-dependent type I IFN induction,
suggesting that TLR3-TRAF3 axis is indispensable in prevention
against HSV-1 infection in the CNS. Whereas UNC93B1-defi-
cient patients are prone to HSE and fail to induce type I IFN in
response to TLR3, TLR7, and TLR9 ligands, IRAK4- and
MyD88-deficient patients who are unresponsive to TLR7 and
TLR9 ligands are otherwise normal against virus infection,
including HSV-1, suggesting that the TLR3-dependent pathway
plays a key role in UNC93B1-associated diseases in humans.
It has been reported that there are associations between TLR
genetic variations and susceptibility or resistance to infections
(Casanova et al., 2011). TLR4 polymorphism Asp299Gly allele
increases the risk of Gram-negative bacteria infection and
sepsis. In addition, TLR4 polymorphism is associated with an
increased risk of asperigillosis, RSV bronchiolitis, and severe
malaria. On the contrary, the same polymorphism increased
resistance to Legionnaires diseases caused by Legionella
pneumophila. TLR5 polymorphism Arg393STOP is oppositely
found to be associated with susceptibility to Legionnaires
diseases. TLR2 polymorphism Arg753Gln, which impairs down-
stream signaling, is associated with susceptibility to tuberculosis
and with the protection from late-stage Lyme disease caused by
the bacterium Borrelia burgdorferi. TLR9 Thr1486Cys polymor-
phism is found to increase the risk of severe malaria. Moreover,
heterozygous of TIRAP Ser180Lue variant is reported to mediate
protection against invasive pneumococcal disease, bacteremia,
malaria, and tuberculosis.
Future Perspectives
Over the past decade, much progress has been made in our
understanding of how the innate immune system senses and
responds to microbial pathogens. The mechanisms underlying
the ligand specificity, signaling pathways, and cellular trafficking
of TLRs have been extensively characterized. However, micro-
bial pathogens consist of multiple PAMPs, which activate both
TLRs and other PRRs, and it is now clear that crosstalk between
them is a prerequisite for the induction of effective innate
immune responses. However, because of the complexity ofthese systems, we still know relatively little about innate immune
recognition of microbial pathogens and the crosstalk between
the different PRRs. Moreover, we also know little about mecha-
nisms of how the innate immune system controls the induction of
adaptive immunity. Thus, comprehensive analysis by means of
mice deficient in each PRR, or in a combination of different
PRRs, will be required before we fully understand the complex
processes involved.
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